Short pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #21,651 to #21,700.
- (hist) Anidulafungin warnings and precautions [438 bytes]
- (hist) Mafenide microbiology [438 bytes]
- (hist) Amitriptyline hydrochloride dosage forms and strengths [438 bytes]
- (hist) Amitriptyline hydrochloride nonclinical toxicology [438 bytes]
- (hist) Amitriptyline hydrochloride clinical studies [438 bytes]
- (hist) Air embolism classification [438 bytes]
- (hist) Chronic diarrhea CT [438 bytes]
- (hist) Mastoiditis Screening [438 bytes]
- (hist) Diphyllobothriasis other imaging findings [438 bytes]
- (hist) Membrane bound o-acyltransferase domain containing 2 [438 bytes]
- (hist) TMIGD1 [438 bytes]
- (hist) Neurexophilin and pc-esterase domain family member 2 [438 bytes]
- (hist) POEMS syndrome screening [438 bytes]
- (hist) COVID-19 approach to patients with elevated biomarkers [438 bytes]
- (hist) Analgesic nephropathy screening [438 bytes]
- (hist) Aminoquinolines [439 bytes]
- (hist) 2nd Skin [439 bytes]
- (hist) Micturition syncope [439 bytes]
- (hist) Alphos [439 bytes]
- (hist) Test-retest [439 bytes]
- (hist) Fibrin sealant [439 bytes]
- (hist) IRB [439 bytes]
- (hist) Research council for complementary medicine [439 bytes]
- (hist) Rush-Copley Medical Center [439 bytes]
- (hist) Hydrocollator [439 bytes]
- (hist) Alexander's law [439 bytes]
- (hist) Aortic valve disease [439 bytes]
- (hist) Stomach cancer future or investigational therapies [439 bytes]
- (hist) Stomach cancer cost-effectiveness of therapy [439 bytes]
- (hist) Pelvic inflammatory disease cost-effectiveness of therapy [439 bytes]
- (hist) Pelvic inflammatory disease future or investigational therapies [439 bytes]
- (hist) Myxoma medical therapy [439 bytes]
- (hist) Blue rubber bleb nevus syndrome primary prevention [439 bytes]
- (hist) Stomach cancer case study one [439 bytes]
- (hist) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency cost-effectiveness of therapy [439 bytes]
- (hist) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency future or investigational therapies [439 bytes]
- (hist) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency case study one [439 bytes]
- (hist) Polycythemia screening [439 bytes]
- (hist) Membranoproliferative glomerulonephritis surgery [439 bytes]
- (hist) Varicocele physical examination [439 bytes]
- (hist) Kyasanur forest disease primary prevention [439 bytes]
- (hist) Pelvic inflammatory disease case study one [439 bytes]
- (hist) Perforated eardrum surgery [439 bytes]
- (hist) Adefovir labels and packages [439 bytes]
- (hist) Fidaxomicinindications and usage [439 bytes]
- (hist) Methysergide dosage forms and strengths [439 bytes]
- (hist) Methysergide clinical studies [439 bytes]
- (hist) Methysergide labels and packages [439 bytes]
- (hist) Drug (patient information) [439 bytes]
- (hist) Diffuse large B cell lymphoma secondary prevention [439 bytes]